GRN and frontotemporal dementia: Firstly, we highlighted the variability of plasma PGRN levels across GRN mutation types, most notably showing levels for missense mutations after the signal peptide to be significantly higher than the other mutation groups, suggesting that the majority of these mutations may not be pathogenic but more likely either risk factors for FTD or just benign polymorphisms.